Purpose of this Study
We are doing this study to collect data about the use and safety of the GORE TAG Conformable Thoracic Stent Graft®. This device is approved by the FDA for the endovascular repair of medical conditions of the aorta (the large blood vessel that runs inside the chest and abdomen).
Who Can Participate?
Eligibility
Adults ages 18+ who have been or will be treated with the GORE TAG Conformable Thoracic Stent Graft.
For more information, contact the study team at francine.bent@duke.edu.
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Description
If you choose to join this study, your participation will start when you are implanted with the GORE TAG Conformable Thoracic Stent Graft according to your doctor's standard surgical procedures. By taking part in the study, you will give us permission to collect information from your medical records at the time of surgery, hospitalization, and your routine follow-up visits. You will not need to make any additional visits or have any extra tests performed for this study.
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System Performance
Principal Investigator
George
Hughes
Protocol Number
PRO00117449
Enrollment Status
Pending Open to Enrollment